Can detection of circulating tumor cells in peripheral blood provide prognostic data in breast cancer?
Gro Wiedswang* and Bjørn Naume
Correspondence *Surgical Department, Ullevål University Hospital, Kirkeveien 165, Oslo N–0407, Norway
Email gro.wiedswang@ulleval.no
This article has no abstract so we have provided the first paragraph of the full text.
Although early detection of breast cancer, implementation of adjuvant systemic therapy and increased use of chemotherapy have improved breast cancer survival, adjuvant treatment decisions are still made on the basis of prognostic parameters that are unable to identify all patients at risk. At the same time, use of these parameters causes the overtreatment of certain patient subgroups.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.